Clinical Trials
4 trialsNCT03774901 2023-04-21
PULSE
Centre Hospitalier Universitaire de Besancon
Phase 2 Unknown
NCT05429866 2023-03-08
Immunological Variables Associated to ICI Toxicity in Cancer Patients
Jules Bordet Institute
Phase 2 Unknown
NCT03950362 2019-05-16
PREVERT
Institut Paoli-Calmettes
Phase 2 Unknown
NCT03341845 2018-05-21
Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC
The Netherlands Cancer Institute
Phase 2 Unknown